Free Trial

Tilray (TLRY) Competitors

Tilray logo
$0.47 -0.01 (-2.88%)
Closing price 04:00 PM Eastern
Extended Trading
$0.47 0.00 (-0.59%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TLRY vs. CRON, CDXC, USNA, MNMD, SNDL, ACB, BTMD, MDWD, CGC, and FTLF

Should you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), SNDL (SNDL), Aurora Cannabis (ACB), biote (BTMD), MediWound (MDWD), Canopy Growth (CGC), and FitLife Brands (FTLF). These companies are all part of the "medicinals & botanicals" industry.

Tilray vs.

Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 9.4% of Tilray shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by insiders. Comparatively, 0.9% of Tilray shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Cronos Group currently has a consensus target price of $3.50, indicating a potential upside of 103.49%. Tilray has a consensus target price of $1.92, indicating a potential upside of 305.39%. Given Tilray's stronger consensus rating and higher possible upside, analysts plainly believe Tilray is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tilray
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.18% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
464
61.13%
Underperform Votes
295
38.87%
TilrayOutperform Votes
448
59.18%
Underperform Votes
309
40.82%

Tilray has a net margin of -30.95% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Tilray's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -2.56% -2.47%
Tilray -30.95%-4.40%-3.57%

Cronos Group has a beta of 1.02, suggesting that its stock price is 2% more volatile than the S&P 500. Comparatively, Tilray has a beta of 1.88, suggesting that its stock price is 88% more volatile than the S&P 500.

In the previous week, Tilray had 27 more articles in the media than Cronos Group. MarketBeat recorded 30 mentions for Tilray and 3 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.75 beat Tilray's score of 0.08 indicating that Cronos Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Tilray
6 Very Positive mention(s)
3 Positive mention(s)
8 Neutral mention(s)
4 Negative mention(s)
2 Very Negative mention(s)
Neutral

Cronos Group has higher earnings, but lower revenue than Tilray. Tilray is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos Group$117.62M5.64-$73.96M$0.1017.20
Tilray$210.48M2.11-$244.98M-$1.05-0.45

Summary

Cronos Group and Tilray tied by winning 9 of the 18 factors compared between the two stocks.

Remove Ads
Get Tilray News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ Exchange
Market Cap$443.32M$1.17B$17.00B$7.57B
Dividend YieldN/AN/A3.03%4.32%
P/E Ratio-1.589.6915.3017.81
Price / Sales2.117.423.6894.60
Price / CashN/A10.4016.3934.64
Price / Book0.111.186.274.00
Net Income-$244.98M-$56.07M$734.35M$247.23M
7 Day Performance3.62%8.39%4.11%7.26%
1 Month Performance-22.48%-10.00%-1.71%-6.26%
1 Year Performance-73.44%-43.04%-2.36%-0.18%

Tilray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
1.5034 of 5 stars
$0.47
-2.9%
$1.92
+305.4%
-73.3%$443.32M$210.48M-1.582,650Earnings Report
Analyst Revision
CRON
Cronos Group
1.5696 of 5 stars
$1.68
-0.3%
$3.50
+109.0%
-31.5%$640.74M$117.62M-12.88450
CDXC
ChromaDex
2.2772 of 5 stars
N/A$9.03
+∞
N/A$611.50M$99.60M787.29120Analyst Forecast
USNA
USANA Health Sciences
4.8276 of 5 stars
$24.98
+1.1%
$36.00
+44.1%
-44.1%$472.15M$854.50M8.831,900News Coverage
MNMD
Mind Medicine (MindMed)
1.9291 of 5 stars
$5.14
-5.4%
$25.11
+389.0%
-42.6%$389.65MN/A-2.2940
SNDL
SNDL
2.9288 of 5 stars
$1.34
+0.4%
$3.63
+171.5%
-33.5%$350.81M$920.45M-4.31580
ACB
Aurora Cannabis
0.5385 of 5 stars
$4.06
+0.2%
N/A-35.6%$228.74M$320.81M81.401,340
BTMD
biote
3.1593 of 5 stars
$3.26
+0.2%
$8.00
+145.8%
-41.4%$178.14M$197.19M12.52194Positive News
MDWD
MediWound
1.3987 of 5 stars
$15.52
+2.9%
$31.33
+101.9%
+3.8%$166.36M$20.22M-5.3280Gap Up
CGC
Canopy Growth
2.2219 of 5 stars
$0.87
-6.9%
$2.00
+130.9%
-86.8%$137.52M$276.75M-0.233,150News Coverage
FTLF
FitLife Brands
4.2047 of 5 stars
$11.36
+8.5%
$20.50
+80.5%
-14.4%$104.74M$64.47M13.4420Gap Up
Remove Ads

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners